Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.37M 1.26M 1.17M 2.21M 149M 2.25M 15.17M 5.9M 73.03M 5.85M 5.72M 254M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.4M -26.22M -24.23M -45.92M -3.1B -46.84M -315M -122M -1.52B -122M -119M -5.27B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 31/03/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 30/11/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 06/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 30/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 19/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 19/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.97% | 1.56M | |
| -0.24% | +1.85% | +3.13% | +8.40% | 49.74B | |
| -1.23% | +0.86% | +418.99% | +595.04% | 40.49B | |
| -2.95% | +3.17% | +22.70% | +55.80% | 34.35B | |
| -2.86% | -0.35% | +23.12% | -7.72% | 34.75B | |
| -0.79% | +2.02% | +3.83% | +36.42% | 26.98B | |
| +2.46% | +2.28% | - | - | 16.58B | |
| -3.55% | -2.80% | +63.83% | +118.51% | 15.6B | |
| -2.50% | +6.32% | +103.66% | +101.52% | 14.27B | |
| -2.70% | -2.04% | +12.37% | +17.77% | 13.76B | |
| Average | -3.97% | +1.01% | +72.40% | +92.53% | 24.65B | |
| Weighted average by Cap. | -1.76% | +4.37% | +93.29% | +133.44% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.31M 1.21M 1.11M 2.11M 143M 2.16M 14.5M 5.64M 69.82M 5.6M 5.47M 242M | 785K 689K 636K 587K 1.11M 75.17M 1.14M 7.64M 2.97M 36.78M 2.95M 2.88M 128M |
| Net income | -44.17M -38.74M -35.77M -33.05M -62.65M -4.23B -63.9M -430M -167M -2.07B -166M -162M -7.18B | -39.48M -34.63M -31.97M -29.54M -55.99M -3.78B -57.11M -384M -149M -1.85B -148M -145M -6.42B |
| Net Debt | -63.64M -55.82M -51.53M -47.62M -90.26M -6.09B -92.06M -619M -241M -2.98B -239M -234M -10.35B | -33.94M -29.77M -27.48M -25.39M -48.13M -3.25B -49.1M -330M -128M -1.59B -127M -125M -5.52B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
